Mammoth Biosciences Stock

mammoth.bio | BioTech | Founded: 2017 | Funding to Date: $68,120,000

Mammoth Biosciences is a biotechnology company that, through the discovery and development of novel CRISPR systems, the is enabling the full potential of its platform to improve lives by reading and writing the code of life.

TEAM

Management Team
  • Trevor Martin Ph.D - Co-Founder & Chief Executive Officer
  • Ted Tisch - Chief Operating Officer
  • Janice Chen Ph.D - Co-Founder & Chief Technology Officer
  • Lucas Harrington - Co-Founder & Chief Scientific Officer
  • Peter Nell Ph.D - Chief Business Officer and Head of Therapeutics
  • Jennifer Doudna Ph.D - Co-Founder & Chairman of Scientific Advisory Board
Board Members
  • Jennifer Doudna Ph.D - Mammoth Biosciences
  • Ursheet Parikh - Mayfield Fund

Other companies like Mammoth Biosciences in the BioTech sector

Ginkgo Bioworks
BioTech
Est. Val.: $4.89B
Human Longevity
BioTech
Est. Val.: $50,396,793
Caribou Biosciences
BioTech
Est. Val.: $143,800,000
Life Biosciences
BioTech
Est. Val.: $500,000,000
American Gene Technologies International
BioTech
Est. Val.: $265,000,000

NEWS

X